Janux Therapeutics Inc
JANX
Market Cap$1.37B
Close$
$4.21
82.4% downside
Current Fair Value
82.4% downsideOvervalued by 82.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.37 Billion |
|---|---|
| Enterprise Value | $1.36 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | 2.85 |
| Outstanding Shares | 61,902,411 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.31 |
|---|---|
| PEG | -2.84 |
| Price to Sales | - |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 3087.46 |
| Enterprise Value to EBIT | -9.36 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Janux Therapeutics Inc
16 employees